期刊文献+

Baicalein对兔角膜上皮细胞的毒性分析 被引量:1

Analysis of toxicity of baicalein in corneal epithelial cells of rabbit
暂未订购
导出
摘要 目的探讨12-LOX选择性抑制剂baicalein的药物毒性,为baicalein的临床应用提供参考。方法体外原代培养兔角膜上皮细胞,加入30μmol/L baicalein继续培养2、4、6d,MTT法测定细胞抑制率。制作兔角膜上皮缺损模型,同浓度baicalein制成滴眼药局部应用,观察其对在体兔角膜上皮增生和移行的影响。结果30μmol/L baicalein对体外原代培养兔角膜上皮细胞作用2d的细胞抑制率为2.6%,作用4d、6d对细胞生长没有明显的抑制作用。缺损闭合实验显示此浓度baicalein对在体兔角膜上皮细胞的增生和移行无任何影响。结论30μmol/L baicalein安全,对兔角膜上皮细胞的生长无影响。 Objective It has been showed that baicalein, a selective inhibitor of 12-LOX, have an inhibition on angiogenesis and suppress corneal neovascularization in rabbits effectively. However, its safety to ocular tissue has not been reported yet. This study tried to investigate the toxicity of baicalein to corneal epithelial cells of rabbit and offer a reference of clinical application of baicalein. Methods Primary cultured corneal epithelial cells of rabbit were exposed to 30 μmol/L baicalein for 2,4,6 days. The inhibition rates of corneal epithelial cells were determined by MTT assay. Rabbit corneal epithelial cells defect models were produced in vivo. Eight models were divided into experimental group and control group. In the experiment group,baiealein in 1% dimethyl sulfoxide (DMSO) and in 10% Tween 20 buffer solution ( the final concentration of baicalein was 30 μmol/L ) was topically applied 4 times daily for 10 days in the right eyes of rabbit,and 1% DMSO and 10% Tween 20 buffer solution only were applied topically in the left eyes in the control group. The defect area of rabbit corneal epithelial cells was assessed at 6,12,18 and 24 hours by Image Pro Plus V4.5 software. Results The inhibiting rate of baicalein on cultured corneal epithelium cells was 2. 6% at 2 days,and no significant suppressing effects were found at 4 and 6 days. No statistically significant differences were seen between experimental group and control group at 2,4,6 days (P 〉 0.05). The defect area of corneal epithelial cells at 0,6, 12 and 18 hours had not statistically significant differences between experimental and control groups. The defect area in the center and periphery of cornea was gradually reduced with time lapse. Conclusion Baicalein at 30 μmol/L is safe to ocular surface tissue during the topical utilization. Baicalein has no significant influence on the proliferation and migration of corneal epithelial cells.
作者 张黎 胡燕华
出处 《眼科研究》 CSCD 北大核心 2007年第7期537-539,共3页 Chinese Ophthalmic Research
关键词 MTT法 毒性 兔角膜上皮细胞 BAICALEIN MTT assay toxiticy corneal epithelial cells baicalein
  • 相关文献

参考文献7

二级参考文献62

  • 1FANXiong-lin,WANGLi-mei,LUXian-yu,TUZhi-guang,SHIChang-hong,XUZhi-kai.Cloning and expression of the fusion protein of interleukin-2 and ESAT6 in Mycobacterium bovis Bacillus Calmette Guérin strain[J].Chinese Medical Journal,2005(9):762-765. 被引量:2
  • 2张黎,胡燕华.新的角膜囊袋法诱生的兔角膜新生血管模型[J].眼科研究,2006,24(3):260-262. 被引量:3
  • 3[1]Dua HS,Azuara-Blanco A. Limbal stem cells of the corneal epithelium.Surv Ophthalmol, 2000;44(5): 415-425
  • 4[2]Ebato B, Friend J, Thoft RA. Comparison of limbal and peripheral human corneal epithelium in tissue culture. Invest Ophthalmol Vis Sci, 1988;29(10):1533-1537
  • 5[3]Gan L, van-Setten G, Seregard S, Fagerholm P. Proliferating cell nuclear antigen colocalization with corneal epithelial stem cells and involvement in physiological cell turnover. Acta Ophthalmol Scand, 1995;73(6):491-495
  • 6[4]Chung EH, DeGregorio PG, Wasson M, Zieske JD. Epithelial regeneration after limbus-to-limbus dehridement. Expression of alpha-enolase in stem and transient amplifying cells. Invest Ophthalmol Vis Sci, 1995;36(7):1336-1343
  • 7[5]Tseng SC, Zhang SH. Interaction between rose bengal and different protein components. Cornea, 1995;14(4): 427-435
  • 8[6]Kruse FE, Tseng SC. Retinoic acid regulates clonal growth and differentiation of cultured limbal and peripheral corneal epithelium. Invest Ophthalmol Vis Sci, 1994;35(5):2405-2420
  • 9[7]Lindberg K, Brown ME, Chaves HV, Kenyon KR, Rheinwald JG. In vitropropagation of human ocular surface epithelial cells for transplantation. Invest Ophthalmol Vis Sci, 1993;34(9):2672-2679
  • 10[8]Tsubota K, Corneal epithelial stem-cell transplantation. Lancet, 1997;24(349):1556

共引文献43

同被引文献9

  • 1Kaltwasser JP, Nash P, Gladman D, et al. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial [ J ]. Arthritis Rheum ,2004,5 (6) : 1939-1950.
  • 2Hardinger KL, Wang CD, Schnitzler MA, et al. Prospective, pilot, openlabel, short-term study of conversion to leflunomide reverses chronic renal allograft dysfunction [ J ]. Am J Transplant,2002,2 ( 9 ) : 867-871.
  • 3Williams JW, Mital D, Chong A, et al. Experiences with leflunomide in solid organ transplantation [ J ]. Transplantation ,2002,73 ( 3 ) : 358-366.
  • 4Seo K, Choi J, Park M, et al. Angiogenesis effects of nerve growth factor (NGF) on rat corneas[J]. J Vet Sci,2001,2(2) : 125-130.
  • 5Kirsch BM, Zeyda M, Stuhlmeier K, et al. The active metabolite of leflunomide, A771726, interferes with dendritic cell function[ J ]. Arthritis Res Ther,2005,7 ( 3 ) : 694-703.
  • 6Fox RL, Herrmann ML, Franqou CG, et al. Mechanism of action for leflunomide in rheumatoid arthritis [ J ]. Clin Immunol, 1999,93 ( 3 ) : 198-208.
  • 7Shawver LK, Schwartz DP, Mann E, et al. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4- ( trifluoromethyl )-phenyl ] 5-methylisoxazole-4-carboxamide [ J ]. Clin Cancer Res, 1997,3 ( 7 ) : 1167-1177.
  • 8Rossant J, Howard L. Signaling pathways in vascular development [ J ]. Ann Rev Cell Dev Biol,2002,18 (2) : 541-573.
  • 9Urushibara M, Takayanagi H, Koga T, et al. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1 [ J ]. Arthritis Rheum ,2004,50 ( 3 ) : 794-804.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部